• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CVM advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of September 30, 2013.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20101014
Nov 20101014
Dec 20101043
Jan 20111043
Feb 20111043
Mar 20111043
Apr 20111043
May 20111043
Jun 20111043
Jul 20111043
Aug 20111043
Sep 20111043

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Number of CVM advisory committee member positions vacant at the end of the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2010N/A2
Nov 2010N/A2
Dec 2010N/A6
Jan 2011N/A6
Feb 2011N/A6
Mar 2011N/A6
Apr 2011N/A6
May 2011N/A6
Jun 2011N/A6
Jul 2011N/A6
Aug 2011N/A6
Sep 2011N/A6

Total number of CVM advisory committee member positions at the end of the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2010N/A14
Nov 2010N/A14
Dec 2010N/A14
Jan 2011N/A14
Feb 2011N/A14
Mar 2011N/A14
Apr 2011N/A14
May 2011N/A14
Jun 2011N/A14
Jul 2011N/A14
Aug 2011N/A14
Sep 2011N/A14

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.